Literature DB >> 15341513

Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure.

Said El Messari1, Xavier Iturrioz, Celine Fassot, Nadia De Mota, Darren Roesch, Catherine Llorens-Cortes.   

Abstract

Apelin is a novel neuropeptide involved in the regulation of body fluid homeostasis and cardiovascular functions. It acts through a G protein-coupled receptor, the APJ receptor. We studied the structure-activity relationships of apelin at the rat apelin receptor, tagged at its C-terminal end with enhanced green fluorescent protein and stably expressed in CHO cells. We evaluated the potency of N- and C-terminal deleted fragments of K17F to bind with high affinity to the apelin receptor, and to inhibit cAMP production and to induce apelin receptor internalization. We first characterized the internalization and trafficking of the rat apelin receptor. This receptor was internalized via a clathrin-dependent mechanism and our results suggest that receptor trafficking may follow a recycling pathway. We then tried to identify the amino acids of K17F required for apelin activity. The first five N-terminal and the last two C-terminal amino acids of K17F were not essential for apelin binding or the inhibition of cAMP production. However, the full-length sequence of K17F was the most potent inducer of apelin receptor internalization because successive N-terminal amino-acid deletions progressively reduced internalization and the removal of a single amino acid at the C-terminus abolished this process. Finally, the most novel observation of this work is that hypotensive actions of apelin peptides correlate best with the ability of those ligands to internalize. Thus, apelin receptor signaling and endocytosis are functionally dissociated, possibly reflecting the existence of several conformational states of this receptor, stabilized by the binding of different apelin fragments to the apelin receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341513     DOI: 10.1111/j.1471-4159.2004.02591.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  47 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

2.  Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli.

Authors:  Michel Azizi; Xavier Iturrioz; Anne Blanchard; Séverine Peyrard; Nadia De Mota; Nicolas Chartrel; Hubert Vaudry; Pierre Corvol; Catherine Llorens-Cortes
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

3.  Limitation of myocardial infarction by a structural analog of the peptide apelin-12.

Authors:  O I Pisarenko; Yu A Pelogeykina; Zh D Bespalova; L I Serebryakova; M V Sidorova; A A Az'muko; D N Khatri; I M Studneva; M E Pal'keeva; O V Tskitishvili; A S Molokoedov
Journal:  Dokl Biol Sci       Date:  2012-05-05

4.  By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization.

Authors:  Xavier Iturrioz; Romain Gerbier; Vincent Leroux; Rodrigo Alvear-Perez; Bernard Maigret; Catherine Llorens-Cortes
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

Review 5.  Apelin, diabetes, and obesity.

Authors:  Isabelle Castan-Laurell; Cédric Dray; Camille Attané; Thibaut Duparc; Claude Knauf; Philippe Valet
Journal:  Endocrine       Date:  2011-08       Impact factor: 3.633

6.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 7.  Advances in therapeutic peptides targeting G protein-coupled receptors.

Authors:  Anthony P Davenport; Conor C G Scully; Chris de Graaf; Alastair J H Brown; Janet J Maguire
Journal:  Nat Rev Drug Discov       Date:  2020-03-19       Impact factor: 84.694

Review 8.  Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.

Authors:  Sanju Narayanan; Danni L Harris; Rangan Maitra; Scott P Runyon
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

Review 9.  Vascular effects of apelin: Mechanisms and therapeutic potential.

Authors:  Amreen Mughal; Stephen T O'Rourke
Journal:  Pharmacol Ther       Date:  2018-05-25       Impact factor: 12.310

10.  Apelin acts in the subfornical organ to influence neuronal excitability and cardiovascular function.

Authors:  Li Dai; Pauline M Smith; Markus Kuksis; Alastair V Ferguson
Journal:  J Physiol       Date:  2013-04-29       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.